Alphatec Holdings, Inc. (ATEC)
USD 10.21
(-2.3%)
USD 10.21
(-2.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 482.26 Million USD | 37.45% |
| 2022 | 350.86 Million USD | 44.26% |
| 2021 | 243.21 Million USD | 67.89% |
| 2020 | 144.86 Million USD | 27.71% |
| 2019 | 113.42 Million USD | 23.7% |
| 2018 | 91.69 Million USD | -9.87% |
| 2017 | 101.73 Million USD | -15.39% |
| 2016 | 120.24 Million USD | -35.1% |
| 2015 | 185.27 Million USD | -10.48% |
| 2014 | 206.98 Million USD | 1.1% |
| 2013 | 204.72 Million USD | 4.3% |
| 2012 | 196.27 Million USD | -0.72% |
| 2011 | 197.71 Million USD | 15.21% |
| 2010 | 171.61 Million USD | 29.85% |
| 2009 | 132.15 Million USD | 30.44% |
| 2008 | 101.31 Million USD | 26.59% |
| 2007 | 80.03 Million USD | 8.14% |
| 2006 | 74 Million USD | 74.85% |
| 2005 | 42.32 Million USD | 137.5% |
| 2004 | 17.82 Million USD | 63.64% |
| 2003 | 10.89 Million USD | -3.94% |
| 2002 | 11.33 Million USD | -18.8% |
| 2001 | 13.96 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 138.47 Million USD | 0.37% |
| 2024 Q3 | 47.99 Million USD | 3.53% |
| 2024 Q2 | 145.57 Million USD | 5.12% |
| 2023 FY | 482.26 Million USD | 37.45% |
| 2023 Q2 | 116.92 Million USD | 7.16% |
| 2023 Q3 | 118.26 Million USD | 1.15% |
| 2023 Q4 | 137.97 Million USD | 16.66% |
| 2023 Q1 | 109.11 Million USD | 2.99% |
| 2022 Q2 | 84.15 Million USD | 18.63% |
| 2022 Q4 | 105.94 Million USD | 17.93% |
| 2022 FY | 350.86 Million USD | 44.26% |
| 2022 Q1 | 70.93 Million USD | -4.1% |
| 2022 Q3 | 89.83 Million USD | 6.76% |
| 2021 Q2 | 62.24 Million USD | 41.09% |
| 2021 Q4 | 73.96 Million USD | 17.62% |
| 2021 FY | 243.21 Million USD | 67.89% |
| 2021 Q1 | 44.12 Million USD | 0.38% |
| 2021 Q3 | 62.88 Million USD | 1.01% |
| 2020 Q2 | 29.62 Million USD | -1.61% |
| 2020 Q3 | 41.16 Million USD | 38.93% |
| 2020 FY | 144.86 Million USD | 27.71% |
| 2020 Q4 | 43.95 Million USD | 6.78% |
| 2020 Q1 | 30.11 Million USD | -6.91% |
| 2019 Q3 | 29.2 Million USD | 6.89% |
| 2019 Q2 | 27.31 Million USD | 11.26% |
| 2019 Q1 | 24.55 Million USD | -3.11% |
| 2019 FY | 113.42 Million USD | 23.7% |
| 2019 Q4 | 32.35 Million USD | 10.79% |
| 2018 Q3 | 23 Million USD | 4.36% |
| 2018 Q4 | 25.34 Million USD | 10.18% |
| 2018 FY | 91.69 Million USD | -9.87% |
| 2018 Q1 | 21.3 Million USD | -18.93% |
| 2018 Q2 | 22.04 Million USD | 3.45% |
| 2017 Q4 | 26.28 Million USD | 13.78% |
| 2017 FY | 101.73 Million USD | -15.39% |
| 2017 Q3 | 23.09 Million USD | -5.25% |
| 2017 Q2 | 24.37 Million USD | -12.86% |
| 2017 Q1 | 27.97 Million USD | 3.28% |
| 2016 FY | 120.24 Million USD | -35.1% |
| 2016 Q1 | 44.76 Million USD | -4.77% |
| 2016 Q4 | 27.09 Million USD | 1.42% |
| 2016 Q3 | 26.71 Million USD | -39.0% |
| 2016 Q2 | 43.79 Million USD | -2.17% |
| 2015 Q1 | 48.64 Million USD | -9.29% |
| 2015 Q4 | 47 Million USD | 9.32% |
| 2015 FY | 185.27 Million USD | -10.48% |
| 2015 Q2 | 46.63 Million USD | -4.14% |
| 2015 Q3 | 42.99 Million USD | -7.8% |
| 2014 Q3 | 51.01 Million USD | -4.05% |
| 2014 FY | 206.98 Million USD | 1.1% |
| 2014 Q4 | 53.62 Million USD | 5.12% |
| 2014 Q1 | 49.17 Million USD | -7.33% |
| 2014 Q2 | 53.16 Million USD | 8.12% |
| 2013 Q4 | 53.06 Million USD | 5.72% |
| 2013 FY | 204.72 Million USD | 4.3% |
| 2013 Q3 | 50.19 Million USD | -1.62% |
| 2013 Q1 | 50.44 Million USD | -4.36% |
| 2013 Q2 | 51.02 Million USD | 1.14% |
| 2012 Q4 | 52.74 Million USD | 12.6% |
| 2012 Q1 | 48.46 Million USD | -2.12% |
| 2012 Q3 | 46.83 Million USD | -2.89% |
| 2012 FY | 196.27 Million USD | -0.72% |
| 2012 Q2 | 48.23 Million USD | -0.47% |
| 2011 Q3 | 47.61 Million USD | -6.38% |
| 2011 FY | 197.71 Million USD | 15.21% |
| 2011 Q4 | 49.51 Million USD | 3.97% |
| 2011 Q2 | 50.86 Million USD | 2.3% |
| 2011 Q1 | 49.72 Million USD | 8.04% |
| 2010 Q1 | 38.43 Million USD | 4.99% |
| 2010 FY | 171.61 Million USD | 29.85% |
| 2010 Q2 | 45.42 Million USD | 18.2% |
| 2010 Q4 | 46.01 Million USD | 2.61% |
| 2010 Q3 | 44.84 Million USD | -1.27% |
| 2009 Q4 | 36.6 Million USD | 12.02% |
| 2009 Q2 | 32.26 Million USD | 5.4% |
| 2009 Q1 | 30.61 Million USD | 7.6% |
| 2009 FY | 132.15 Million USD | 30.44% |
| 2009 Q3 | 32.67 Million USD | 1.28% |
| 2008 Q2 | 23.85 Million USD | 2.83% |
| 2008 FY | 101.31 Million USD | 26.59% |
| 2008 Q4 | 28.44 Million USD | 10.19% |
| 2008 Q1 | 23.19 Million USD | 8.69% |
| 2008 Q3 | 25.81 Million USD | 8.23% |
| 2007 FY | 80.03 Million USD | 8.14% |
| 2007 Q2 | 18.82 Million USD | -3.73% |
| 2007 Q3 | 20.31 Million USD | 7.96% |
| 2007 Q4 | 21.34 Million USD | 5.03% |
| 2007 Q1 | 19.55 Million USD | 1.84% |
| 2006 FY | 74 Million USD | 74.85% |
| 2006 Q4 | 19.19 Million USD | 10.59% |
| 2006 Q1 | 18.02 Million USD | 52.69% |
| 2006 Q2 | 19.42 Million USD | 7.72% |
| 2006 Q3 | 17.35 Million USD | -10.63% |
| 2005 Q2 | 11.8 Million USD | 71.1% |
| 2005 Q4 | 11.8 Million USD | 0.0% |
| 2005 Q1 | 6.9 Million USD | 54.9% |
| 2005 Q3 | 11.8 Million USD | 0.0% |
| 2005 FY | 42.32 Million USD | 137.5% |
| 2004 Q3 | 4.45 Million USD | 0.0% |
| 2004 Q1 | 4.45 Million USD | 0.0% |
| 2004 Q2 | 4.45 Million USD | 0.0% |
| 2004 Q4 | 4.45 Million USD | -0.0% |
| 2004 FY | 17.82 Million USD | 63.64% |
| 2003 FY | 10.89 Million USD | -3.94% |
| 2002 FY | 11.33 Million USD | -18.8% |
| 2001 FY | 13.96 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -6631.742% |
| Cerus Corporation | 156.36 Million USD | -208.417% |
| OrthoPediatrics Corp. | 148.73 Million USD | -224.249% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -49684.145% |
| Talis Biomedical Corporation | 412 Thousand USD | -116953.883% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -3394.399% |
| Inogen, Inc. | 315.66 Million USD | -52.779% |
| Spectral AI, Inc. | 18.05 Million USD | -2570.924% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -4768.874% |
| CVRx, Inc. | 39.29 Million USD | -1127.286% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -74785.404% |
| Orthofix Medical Inc. | 746.64 Million USD | 35.409% |
| Venus Concept Inc. | 76.35 Million USD | -531.613% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -3899.187% |
| Bioventus Inc. | 512.34 Million USD | 5.872% |
| BrainsWay Ltd. | 31.78 Million USD | -1417.263% |
| Envoy Medical, Inc. | 316 Thousand USD | -152514.557% |
| electroCore, Inc. | 16.03 Million USD | -2908.497% |
| IceCure Medical Ltd | 3.22 Million USD | -14835.336% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -19762.521% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -132026.937% |
| MaxCyte, Inc. | 41.28 Million USD | -1068.044% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -24600.465% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -435358.88% |
| PAVmed Inc | 2.45 Million USD | -19568.108% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -2041.578% |
| RxSight, Inc. | 89.07 Million USD | -441.399% |
| Sight Sciences, Inc. | 81.05 Million USD | -494.974% |
| SI-BONE, Inc. | 138.88 Million USD | -247.236% |
| TELA Bio, Inc. | 58.45 Million USD | -725.042% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -2505.273% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -157.731% |
| LivaNova PLC | 1.15 Billion USD | 58.193% |
| 908 Devices Inc. | 50.22 Million USD | -860.127% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -625856.596% |
| NeuroPace, Inc. | 65.42 Million USD | -637.167% |
| LENSAR, Inc. | 42.16 Million USD | -1043.777% |
| Apyx Medical Corporation | 52.34 Million USD | -821.244% |
| Cutera, Inc. | 212.36 Million USD | -127.087% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -1345.716% |
| BioSig Technologies, Inc. | 18 Thousand USD | -2679133.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -189.365% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -1913.2% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 68.716% |
| Axonics, Inc. | 366.37 Million USD | -31.629% |
| Outset Medical, Inc. | 130.37 Million USD | -269.901% |
| IRIDEX Corporation | 51.86 Million USD | -829.769% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -254.107% |
| IRadimed Corporation | 65.56 Million USD | -635.578% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -40908.673% |
| INVO Bioscience, Inc. | 3.02 Million USD | -15865.901% |
| Telesis Bio, Inc. | 27.5 Million USD | -1653.106% |
| Viemed Healthcare, Inc. | 183 Million USD | -163.52% |
| Varex Imaging Corporation | 811 Million USD | 40.535% |
| Quipt Home Medical Corp. | 221.74 Million USD | -117.488% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -602.238% |
| Dynatronics Corporation | 32.53 Million USD | -1382.334% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -5457.294% |
| Semler Scientific, Inc. | 68.18 Million USD | -607.295% |
| InMode Ltd. | 492.04 Million USD | 1.989% |
| Bruker Corporation | 2.96 Billion USD | 83.732% |
| Cytosorbents Corporation | 36.34 Million USD | -1226.741% |
| DexCom, Inc. | 3.62 Billion USD | 86.686% |
| Align Technology, Inc. | 3.86 Billion USD | 87.513% |
| Viveve Medical, Inc. | 6.42 Million USD | -7404.855% |
| ZimVie Inc. | 457.43 Million USD | -5.428% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -149.857% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -435358.88% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 35.502% |
| Profound Medical Corp. | 7.33 Million USD | -6478.374% |
| Insulet Corporation | 1.69 Billion USD | 71.583% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -282.511% |
| iCAD, Inc. | 17.31 Million USD | -2684.744% |
| Nuwellis, Inc. | 8.86 Million USD | -5340.681% |
| Biotricity, Inc. | 12.06 Million USD | -3897.747% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 2.115% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -7672.151% |
| PAVmed Inc. | 2.45 Million USD | -19568.108% |
| BIOLASE, Inc. | 49.16 Million USD | -880.925% |
| Beyond Air, Inc. | 1.15 Million USD | -41510.181% |
| FONAR Corporation | 102.88 Million USD | -368.743% |
| AxoGen, Inc. | 159.01 Million USD | -203.287% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -75.737% |
| Inari Medical, Inc. | 493.63 Million USD | 2.303% |
| UFP Technologies, Inc. | 400.07 Million USD | -20.544% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -2592706.452% |
| Tenon Medical, Inc. | 2.92 Million USD | -16370.697% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -6979.555% |
| AdaptHealth Corp. | 3.2 Billion USD | 84.93% |
| Sintx Technologies, Inc. | 2.62 Million USD | -18257.899% |
| NanoVibronix, Inc. | 2.28 Million USD | -21024.047% |
| Quanterix Corporation | 122.36 Million USD | -294.108% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -1876.079% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -140.504% |
| TransMedics Group, Inc. | 241.62 Million USD | -99.593% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -3381.031% |
| NeuroMetrix, Inc. | 5.9 Million USD | -8071.958% |
| Hyperfine, Inc. | 11.03 Million USD | -4271.483% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -192.013% |
| Biomerica, Inc. | 5.41 Million USD | -8806.039% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -853.822% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -172.258% |